文献速递肿瘤 PET/CT

PET/CT在泌尿生殖系统肿瘤中的局限性与陷阱

PET/CT Limitations and Pitfalls in Urogenital Cancers.
PubMed 文献 · Semin Nucl Med · 2021-07-06

本文综述了FDG PET/CT在泌尿生殖系统恶性肿瘤应用中的局限性与常见陷阱。由于这类肿瘤的FDG亲和力差异大、解剖部位特殊及CT与PET序贯成像的技术挑战,图像判读易出现假阳性、假阴性及疗效代谢变化评估错误。目前FDG PET/CT并非早期或低危泌尿生殖系统肿瘤初始诊断或分期的标准,但可用于高危患者远处转移、治疗反应及复发的评估。

要点

  • FDG PET/CT并非早期或低危泌尿生殖系统肿瘤初始诊断或分期的标准。
  • 高危患者可用FDG PET/CT评估远处转移、治疗反应和疾病复发。
  • 认识肿瘤代谢亲和力特征和陷阱对准确判读至关重要。

核心结论

  • FDG PET/CT在泌尿生殖系统肿瘤诊断中判读困难且陷阱多,可导致假阳性、假阴性及治疗后代谢变化评估错误。
  • 目前FDG PET/CT不是早期或低危泌尿生殖系统肿瘤初始诊断或分期的标准治疗。
  • 在高危患者中,FDG PET/CT有助于评估远处转移、治疗反应和疾病复发。

研究设计与样本

  • 本文为综述,总结FDG PET/CT在泌尿生殖系统肿瘤中的局限性与判读陷阱。

主要发现

  • 泌尿生殖系统肿瘤的FDG亲和力存在差异,且肿瘤部位特殊、CT与PET序贯成像存在技术挑战,使PET/CT判读尤为困难。
  • 判读陷阱可导致假阳性和假阴性诊断,以及治疗后代谢变化的错误评估。

临床怎么用

  • 在高危泌尿生殖系统肿瘤患者中,可考虑使用FDG PET/CT评估远处转移、治疗反应和疾病复发。
  • 判读FDG PET/CT时需了解肿瘤代谢亲和力特征及常见陷阱,以提高诊断准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hybrid FDG PET/CT plays a vital role in oncologic imaging and has been widely adopted for the staging and restaging of a variety of malignancies. Its diagnostic value in urogenital malignancies is less well-known, not at least because of the variable FDG avidity of these tumor entities, the sites of these tumors, and technical challenges associated with sequential imaging of CT and PET. PET/CT interpretation thus can be especially challenging and is associated with many pitfalls, which can lead to both false-positive and false-negative diagnoses as well as incorrect assessment of metabolic change following therapy. Currently, FDG PET/CT is not the standard of care for the initial diagnosis or staging of early-stage or low-risk urogenital cancers; however, it can help evaluate distant metastatic disease, response to therapy, and disease recurrence in high-risk patients. Knowledge of imaging features of tumor metabolic avidity and pitfalls is essential for accurate interpretation.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Vasireddi A, Nguyen NC. PET/CT Limitations and Pitfalls in Urogenital Cancers. Semin Nucl Med. 2021. PMID: 34243903. doi:10.1053/j.semnuclmed.2021.06.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。